From: Micro-costing studies in the health and medical literature: protocol for a systematic review
Phase 1 screening: | Â |
 | Full length article (yes/no) |
 | Original research article (yes/no) |
 | Economic evaluation (yes/no) |
 | Health- or healthcare-related (yes/no) |
 | Other reason for exclusion (yes/no, and if yes, specify the reason) |
 | All phase 1 screening criteria met (yes/no) |
Phase 2 screening (if all phase 1 screening criteria are met): | |
 | Costing methods clear (yes/no) |
 | Applied gross-costing (entirely gross-costing, partial gross-costing, no gross-costing, or not clear) |
 | Applied micro-costing (yes, no, or not clear) |
 | Extent of micro-costing (if micro-costing used): for example, whether micro-costing was used for the entire study or for part of the study |
 | Type of micro-costing (if micro-costing used): patient-level direct enumeration and unit cost of all inputs consumed; program-level direct enumeration and unit cost of all inputs consumed, then allocated to each participant; and so on. |
 | Applied other costing methods (yes, no, or not clear, and if yes, specify the methods used) |
 | Whether authors referred to their study as micro-costing (yes/no) |
 | Whether to include the article in final data extraction (yes/no) |
 | Any additional notes about this article |